| Year |
Citation |
Score |
| 2019 |
Knight M, Stanley S. HIF-1α as a central mediator of cellular resistance to intracellular pathogens. Current Opinion in Immunology. 60: 111-116. PMID 31229914 DOI: 10.1016/J.Coi.2019.05.005 |
0.33 |
|
| 2018 |
Van Dis E, Sogi KM, Rae CS, Sivick KE, Surh NH, Leong ML, Kanne DB, Metchette K, Leong JJ, Bruml JR, Chen V, Heydari K, Cadieux N, Evans T, McWhirter SM, ... ... Stanley SA, et al. STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection. Cell Reports. 23: 1435-1447. PMID 29719256 DOI: 10.1016/J.Celrep.2018.04.003 |
0.305 |
|
| 2018 |
Knight M, Braverman J, Asfaha K, Gronert K, Stanley S. Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense. Plos Pathogens. 14: e1006874. PMID 29370315 DOI: 10.1371/Journal.Ppat.1006874 |
0.416 |
|
| 2017 |
Braverman J, Stanley SA. Nitric Oxide Modulates Macrophage Responses to Mycobacterium tuberculosis Infection through Activation of HIF-1α and Repression of NF-κB. Journal of Immunology (Baltimore, Md. : 1950). PMID 28754681 DOI: 10.4049/Jimmunol.1700515 |
0.417 |
|
| 2017 |
Sogi KM, Lien KA, Johnson J, Krogan NJ, Stanley S. The tyrosine kinase inhibitor gefitinib restricts Mycobacterium tuberculosis growth through increased lysosomal biogenesis and modulation of cytokine signaling. Acs Infectious Diseases. PMID 28537707 DOI: 10.1021/Acsinfecdis.7B00046 |
0.41 |
|
| 2016 |
Braverman J, Sogi KM, Benjamin D, Nomura DK, Stanley SA. HIF-1α Is an Essential Mediator of IFN-γ-Dependent Immunity to Mycobacterium tuberculosis. Journal of Immunology (Baltimore, Md. : 1950). PMID 27430718 DOI: 10.4049/Jimmunol.1600266 |
0.384 |
|
| 2014 |
Stanley SA, Barczak AK, Silvis MR, Luo SS, Sogi K, Vokes M, Bray MA, Carpenter AE, Moore CB, Siddiqi N, Rubin EJ, Hung DT. Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. Plos Pathogens. 10: e1003946. PMID 24586159 DOI: 10.1371/Journal.Ppat.1003946 |
0.419 |
|
| 2013 |
Grant SS, Kawate T, Nag PP, Silvis MR, Gordon K, Stanley SA, Kazyanskaya E, Nietupski R, Golas A, Fitzgerald M, Cho S, Franzblau SG, Hung DT. Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model. Acs Chemical Biology. 8: 2224-34. PMID 23898841 DOI: 10.1021/Cb4004817 |
0.354 |
|
| 2013 |
Stanley SA, Cox JS. Host-pathogen interactions during Mycobacterium tuberculosis infections. Current Topics in Microbiology and Immunology. 374: 211-41. PMID 23881288 DOI: 10.1007/82_2013_332 |
0.378 |
|
| 2013 |
Stanley SA, Kawate T, Iwase N, Shimizu M, Clatworthy AE, Kazyanskaya E, Sacchettini JC, Ioerger TR, Siddiqi NA, Minami S, Aquadro JA, Grant SS, Rubin EJ, Hung DT. Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32. Proceedings of the National Academy of Sciences of the United States of America. 110: 11565-70. PMID 23798446 DOI: 10.1073/Pnas.1302114110 |
0.369 |
|
| 2012 |
McMahon TC, Stanley S, Kazyanskaya E, Hung D, Wood JL. The first synthesis of an epidiselenodiketopiperazine. Organic Letters. 14: 4534-6. PMID 22913407 DOI: 10.1021/Ol3020094 |
0.305 |
|
| 2012 |
Stanley SA, Grant SS, Kawate T, Iwase N, Shimizu M, Wivagg C, Silvis M, Kazyanskaya E, Aquadro J, Golas A, Fitzgerald M, Dai H, Zhang L, Hung DT. Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening. Acs Chemical Biology. 7: 1377-84. PMID 22577943 DOI: 10.1021/Cb300151M |
0.349 |
|
| 2009 |
Stanley SA, Hung DT. Chemical tools for dissecting bacterial physiology and virulence. Biochemistry. 48: 8776-86. PMID 19653697 DOI: 10.1021/Bi9009083 |
0.335 |
|
| 2007 |
Voehringer D, Stanley SA, Cox JS, Completo GC, Lowary TL, Locksley RM. Nippostrongylus brasiliensis: identification of intelectin-1 and -2 as Stat6-dependent genes expressed in lung and intestine during infection. Experimental Parasitology. 116: 458-66. PMID 17420014 DOI: 10.1016/J.Exppara.2007.02.015 |
0.331 |
|
| 2007 |
Stanley SA, Johndrow JE, Manzanillo P, Cox JS. The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. Journal of Immunology (Baltimore, Md. : 1950). 178: 3143-52. PMID 17312162 DOI: 10.4049/Jimmunol.178.5.3143 |
0.391 |
|
| 2006 |
Champion PA, Stanley SA, Champion MM, Brown EJ, Cox JS. C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis. Science (New York, N.Y.). 313: 1632-6. PMID 16973880 DOI: 10.1126/Science.1131167 |
0.372 |
|
| 2005 |
MacGurn JA, Raghavan S, Stanley SA, Cox JS. A non-RD1 gene cluster is required for Snm secretion in Mycobacterium tuberculosis. Molecular Microbiology. 57: 1653-63. PMID 16135231 DOI: 10.1111/J.1365-2958.2005.04800.X |
0.339 |
|
| 2003 |
Stanley SA, Raghavan S, Hwang WW, Cox JS. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proceedings of the National Academy of Sciences of the United States of America. 100: 13001-6. PMID 14557536 DOI: 10.1073/Pnas.2235593100 |
0.412 |
|
| 2003 |
Corn RA, Aronica MA, Zhang F, Tong Y, Stanley SA, Kim SR, Stephenson L, Enerson B, McCarthy S, Mora A, Boothby M. T cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 response. Journal of Immunology (Baltimore, Md. : 1950). 171: 1816-24. PMID 12902482 DOI: 10.4049/Jimmunol.171.4.1816 |
0.311 |
|
| Show low-probability matches. |